Faster global financial news!
Google's AI drug discovery company, Isomorphic Labs, is in talks for a new funding round at a valuation of at least $40 billion, potentially reaching $50 billion, just five months after its last funding round.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Understanding Bitcoin Transaction Mechanisms: The Flow of Decentralized Digital Value
-
2
CVXFXS Token Analysis: Role and Future Outlook in the Convex Finance Ecosystem
-
3
Ethereum Market Acceptance and Adoption Strategies Analysis
-
4
U.S. 30-year fixed mortgage rate surged 19 bps to 7.49%, highest since Nov 2023 as Treasury yields surged; mortgage applications fell 4.2% last week.
-
5
Three years on, October 7 events continue to reshape Israel's politics and global standing
-
6
U.S. Secretary of State Rubio: Iran Missed "Multiple" Opportunities to Reach Nuclear Deal
-
7
YAW Token Analysis: Current Status and Challenges of the Solana NFT Marketplace Token
-
8
TON Renamed Gram: In-depth Analysis of MTONGA Roadmap Progress and Revival Confidence
-
9
Hyperliquid Confirms Singapore Base, Lacks MAS License
-
10
NEAR co-founder Polosukhin believes expanding onchain tools will reduce need for centralized exchanges
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
